✦ LIBER ✦

Peg-interferon and ribavirin therapy is safe and effective among HCV patients with thalassaemia major

✍ Scribed by D’Ambrosio, R.; Poggiali, E.; Mazzoleni, M.; Aghemo, A.; Lai, M.E.; Cianciulli, P.; Colombo, M.; Cappellini, M.D.

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

P1216 EFFICACY AND SAFETY OF SIMEPREVIR

✍ Nakajima, T.; Kimura, M.; Arakawa, T.; Kuwata, Y.; Ozeki, I.; Sato, T.; Ohmura, 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 59 KB

Optimizing PEG-interferon and ribavirin

✍ Alfredo Alberti 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 89 KB

Estimates of HCV-1 Patients Attaining RV

✍ Andriulli, A.; Iacobellis, A.; Valvano, M. R.; Spirito, F.; Ippolito, A.; Bossa, 📂 Article 📅 2012 🏛 Springer US 🌐 English ⚖ 572 KB

858 COULD PEG-INTERFERON AND RIBAVIRIN B

✍ Madonia, S.; Barone, R.; Restivo Pantalone, G.; Sinagra, E.; Perricone, G.; Rend 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 155 KB

Ribavirin dosage in patients with HCV ge

✍ A. MANGIA; O. DALGARD; N. MINERVA; H. VERBAAN; D. BACCA; H. RING-LARSEN; M. COPE 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 132 KB

873 A SCORING MODEL FOR PREDICTION OF RE

✍ Shahin, Y.; Metwally, M.A.; Shaheen, W.; El Fiky, H.; Moawad, S. 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 73 KB